Publications by authors named "Gerard Francis Mangubat"
Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trials.
Frederick Berro Rivera Marielle Nicole Cabusas Chin Polyn Luz S Pine Monica Marie Jadena Ruyeras Danica Janine Cabahug Galang Gerard Francis Mangubat
Curr Med Res Opin
December 2024
Article Synopsis
- GLP-1 receptor agonists (GLP-1RAs) show a modest decrease in low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) based on a review of clinical trials.
- The analysis found no significant impact on triglycerides, very low-density lipoprotein cholesterol (VLDL-C), or high-density lipoprotein cholesterol (HDL-C).
- Weight changes did not have a notable effect on LDL-C or TC levels among study participants.
Patients with acromegaly carry a high risk of developing cardiovascular diseases (CVD). In fact, CVD is the leading cause of mortality among this group of patients. The most frequent cardiovascular complications are heart failure (HF), valvular disease, hypertension, arrhythmias, and coronary artery disease (CAD).
View Article and Find Full Text PDFMaternal and neonatal outcomes among pregnant women with cardiovascular disease in the Philippines: a retrospective cross-sectional study from 2015-2019.
Frederick Berro Rivera John Vincent Magalong Ourlad Alzeus Tantengco Gerard Francis Mangubat Mary Grace Villafuerte
J Matern Fetal Neonatal Med
December 2022
Purpose: Several studies link maternal cardiovascular disease (CVD) to maternal and fetal morbidity and mortality. This study describes the profile of maternal, obstetric, and neonatal outcomes among pregnant women with CVD in a tertiary hospital in the Philippines. It identifies the clinical and sociodemographic variables associated with these outcomes.
View Article and Find Full Text PDF